Radical Improvement of Cancer Treatment without Additional Negative Side Effects
We have developed a device – called HyperCollar4D – that significantly increases the effectiveness of radiotherapy for head and neck (H&N) cancer. The first results on 70 patients have proven that our technology yields +50% comple...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PLEC2022-009476
Advanced dosimetry for novel radiotherapy approaches in brai...
307K€
Cerrado
PDC2021-121424-I00
BIOPSIA Y TEJIDO EN UN CHIP MAS BIOSENSORES MULTIPLEXADOS IN...
138K€
Cerrado
JCI-2011-11484
New remote computational intensive methods for Radiotherapy
96K€
Cerrado
RTC-2016-5702-1
Desarrollo y homologación de equipo clínico compacto de reso...
475K€
Cerrado
PTA2011-6139-I
Desarrollo de nuevos dispositivos de imagen y optimización d...
57K€
Cerrado
Información proyecto HyperCollar4D
Duración del proyecto: 36 meses
Fecha Inicio: 2022-06-17
Fecha Fin: 2025-06-30
Líder del proyecto
SENSIUS BV
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
9M€
Descripción del proyecto
We have developed a device – called HyperCollar4D – that significantly increases the effectiveness of radiotherapy for head and neck (H&N) cancer. The first results on 70 patients have proven that our technology yields +50% complete response with respect to radiotherapy alone. The HyperCollar4D is based on hyperthermia: warming up the tumor to 43 ˚C improves its sensitivity to radiotherapy. Hyperthermia yields no lasting toxicity, unlike radiotherapy and chemotherapy. The challenge with hyperthermia is delivering it effectively (i.e., heating only the tumor and not the nearby tissues) and cost-efficiently. The HyperCollar4D is the first device to achieve effective and cost-efficient hyperthermia treatments for H&N cancer. Our technology (called ‘thermotherapy’) is protected by two patents (one granted and one filed). The HyperCollar4D design is modular, so it can be extended to add modules to treat other kinds of cancers. Sensius is a spin-off of the Erasmus Medical Center.